News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn Faculty Weighs in On the Future of American Science
John Wherry, PhD, the Richard and Barbara Schiffrin President's Distinguished Professor at Penn Medicine, explains how decades of federal funding for basic science enabled breakthroughs.
Penn Partners in New National Science Foundation AI Institute for Human-AI Cooperation
The institute will bring together more than 40 partners across academia, industry, government, healthcare, and nonprofit organizations to transform the role of AI in healthcare.
Penn Partners with Six Pennsylvania Research Universities, the Pittsburgh Supercomputing Center, and the State of Pennsylvania to Drive AI and Quantum Research
This collaboration, known as Keystone AI + Quantum Factory, will allow institutions to share high-end computing infrastructure and pursue commercial applications for emerging technologies.
PA State Budget Passes with $125 million Investment in Pennsylvania’s Life Sciences Industry
The budget includes the Innovate in PA 2.0 Program, which will provide capital for startups, fund clinical trials for life sciences and improve the Commonwealth's innovation network.
CAR T Cell Therapy for Lymphoma Leads to 10 Year Remissions for Patients
The follow-up study of patients ten years later showed promising results.
ARPA-H Awards $43 million to Philadelphia Gene Therapy Researchers to Advance Rare Disease Treatments
Learn more about the recipients.
Featured Technology: Leaf Sense
Cherie Kagan, PhD, the Stephen J. Angello Professor of Electrical and Systems Engineering at Penn Engineering, invented small, biodegradable leaf sensors that can measure the health of plants.
BioAdvance Capital Invests in Penn Life Sciences Startups
These investments will support the startups in further developing their treatments and technologies.
Network Bio Launches with $50 million in Funding to Create a Research Network of Large Biobanks to Drive AI Medical Research
Several U.S. Academic Medical Centers, including Penn Medicine, have partnered with Network Bio to generate large-scale multi-omic and multi-modal datasets.
Dispatch Bio Initiates Clinical Trials for a New Type of Cancer Treatment
The technology is intended to overcome a key limitation of current CAR-T cell therapies by broadening the range of tumors that can be targeted and treated.